Rising Debt And European Regulation Will Hamper Eldercare

AnalystLowTarget

Not Invested

Consensus Narrative from 6 Analysts

Published

28 Aug 25

AnalystLowTarget's Fair Value

€4.00

5.4% overvalued

28 Aug

€4.22

129.2%

-1.1%

129.2%

-1.1%

You can edit this narrative until Aug 28 10:19 PM. Then, changes will post as Updates.

Author's Valuation

€4.0

5.4% overvalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

€4

5.4% overvalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

4.55%

Healthcare Services revenue growth rate

0.24%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

12.10%

Calculation

€56.12m

Earnings '28

36.31x

PE Ratio '28

€2.04b

Market Cap '28

€2.04b

Market Cap '28

365.88m

No. shares '28

€5.57

Share Price '28

€5.57 Share Price '28

Discounted to 2025 @ 11.65% p.a.

€4.00

Fair Value '25